PRELUDE THERAPEUTICS
PRLD Insider Trades:
all
Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
10b5-1
Director
10% Owner
Mcap/AUM
2025-06-12
2025-06-13
BABLER MARTIN
A - Grant
Director Stock Option (Right to Buy)
38,000
$0.00
1
$48.62M
2025-06-12
2025-06-13
BONITA DAVID
A - Grant
Director Stock Option (Right to Buy)
38,000
$0.00
1
$48.62M
2025-06-12
2025-06-13
BAKER BROS. ADVISORS LP
A - Grant
Non- Qualified Stock Option (right to buy)
152K
$0.00
2
$48.62M
2025-06-12
2025-06-13
FRIEDMAN PAUL
A - Grant
Director Stock Option (Right to Buy)
38,000
$0.00
1
$48.62M
2025-06-12
2025-06-13
SANDOR VICTOR
A - Grant
Director Stock Option (Right to Buy)
38,000
$0.00
1
$48.62M
2025-04-04
2025-04-07
HUANG JANE
President, CMO
M - Exercise
Restricted Stock Unit
-9,375
$0.00
1
$48.62M
2025-03-25
2025-03-27
COMBS ANDREW
Chief Chemistry Officer
P - Purchase
Common Stock
100K
$1.00
100K
1
$48.62M
2025-02-04
2025-02-05
COMBS ANDREW
Chief Chemistry Officer
A - Grant
Employee Stock Option (right to buy)
175K
$0.00
1
$48.62M
2025-02-04
2025-02-05
HUANG JANE
President, CMO
A - Grant
Employee Stock Option (right to buy)
200K
$0.00
1
$48.62M
2025-02-04
2025-02-05
LIM BRYANT DAVID
CLO, CFO, Corp Sec.
A - Grant
Employee Stock Option (right to buy)
200K
$0.00
1
$48.62M
2025-02-04
2025-02-05
SCHERLE PEGGY
Chief Scientific Officer
A - Grant
Employee Stock Option (right to buy)
175K
$0.00
1
$48.62M
2025-02-04
2025-02-05
VADDI KRISHNA
CEO
A - Grant
Employee Stock Option (right to buy)
496K
$0.00
1
$48.62M
2024-12-23
2024-12-26
COMBS ANDREW
Chief Chemistry Officer
P - Purchase
Common Stock
60,000
$1.00
60,000
1
$48.62M
2024-12-20
2024-12-26
COMBS ANDREW
Chief Chemistry Officer
P - Purchase
Common Stock
3,075
$1.00
3,075
1
$48.62M
2024-12-19
2024-12-20
LIM BRYANT DAVID
CLO, Interim CFO, Corp Sec.
P - Purchase
Common Stock
25,000
$1.00
25,000
1
$48.62M
2024-10-04
2024-10-07
HUANG JANE
President, CMO
M - Exercise
Restricted Stock Unit
-9,375
$0.00
1
$48.62M
2024-07-04
2024-07-08
HUANG JANE
President, CMO
M - Exercise
Restricted Stock Unit
-9,375
$0.00
1
$48.62M
2024-06-14
2024-06-18
BABLER MARTIN
A - Grant
Director Stock Option (Right to Buy)
23,500
$0.00
1
$48.62M
2024-06-14
2024-06-18
BAKER BROS. ADVISORS LP
A - Grant
Non- Qualified Stock Option (right to buy)
47,000
$0.00
2
$48.62M
2024-06-14
2024-06-18
BONITA DAVID
A - Grant
Director Stock Option (Right to Buy)
23,500
$0.00
1
$48.62M
2024-06-14
2024-06-18
FRIEDMAN PAUL
A - Grant
Director Stock Option (Right to Buy)
23,500
$0.00
1
$48.62M
2024-06-14
2024-06-18
SANDOR VICTOR
A - Grant
Director Stock Option (Right to Buy)
23,500
$0.00
1
$48.62M
2024-05-14
2024-05-16
LIM BRYANT DAVID
CLO, Interim CFO, Corp Sec.
A - Grant
Employee Stock Option (Right to Buy)
25,000
$0.00
1
$48.62M
2024-04-04
2024-04-08
HUANG JANE
President, CMO
M - Exercise
Restricted Stock Unit
-9,375
$0.00
1
$48.62M
2024-03-01
2024-03-04
CHARDONNET LAURENT
Chief Financial Officer
A - Grant
Employee Stock Option (right to buy)
150K
$0.00
1
$48.62M
2024-03-01
2024-03-04
COMBS ANDREW
Chief Chemistry Officer
A - Grant
Employee Stock Option (right to buy)
150K
$0.00
1
$48.62M
2024-03-01
2024-03-04
HUANG JANE
President, CMO
A - Grant
Employee Stock Option (right to buy)
175K
$0.00
1
$48.62M
2024-03-01
2024-03-04
LIM BRYANT DAVID
Chief Legal Officer, Corp Sec.
A - Grant
Employee Stock Option (right to buy)
150K
$0.00
1
$48.62M
2024-03-01
2024-03-04
SCHERLE PEGGY
Chief Scientific Officer
A - Grant
Employee Stock Option (right to buy)
150K
$0.00
1
$48.62M
2024-03-01
2024-03-04
VADDI KRISHNA
CEO
A - Grant
Employee Stock Option (right to buy)
425K
$0.00
1
$48.62M
2024-01-04
2024-01-08
HUANG JANE
President, CMO
M - Exercise
Restricted Stock Unit
-9,375
$0.00
1
$48.62M
2023-12-13
2023-12-13
BAKER BROS. ADVISORS LP
A - Grant
Warrants to purchase Common Stock
7.94M
$3.00
24M
2
$48.62M
2023-07-04
2023-07-06
HUANG JANE
President, CMO
M - Exercise
Restricted Stock Unit
-9,375
$0.00
1
$48.62M
2023-06-16
2023-06-21
BABLER MARTIN
A - Grant
Director Stock Option (Right to Buy)
23,500
$0.00
1
$48.62M
2023-06-16
2023-06-21
BAKER BROS. ADVISORS LP
A - Grant
Non- Qualified Stock Option (right to buy)
47,000
$0.00
2
$48.62M
2023-06-16
2023-06-21
BONITA DAVID
A - Grant
Director Stock Option (Right to Buy)
23,500
$0.00
1
$48.62M
2023-06-16
2023-06-21
FRIEDMAN PAUL
A - Grant
Director Stock Option (Right to Buy)
23,500
$0.00
1
$48.62M
2023-06-16
2023-06-21
SANDOR VICTOR
A - Grant
Director Stock Option (Right to Buy)
23,500
$0.00
1
$48.62M
2023-05-24
2023-05-25
LIM BRYANT DAVID
Chief Legal Officer, Corp Sec.
P - Purchase
Common Stock
2,400
$5.00
12,000
1
$48.62M
2023-05-23
2023-05-25
CHARDONNET LAURENT
Chief Financial Officer
P - Purchase
Common Stock
5,000
$6.00
30,000
1
$48.62M
2023-05-22
2023-05-24
BAKER BROS. ADVISORS LP
A - Grant
Warrants to purchase Common Stock
12M
$6.00
70M
2
$48.62M
2023-05-22
2023-05-24
BAKER BROS. ADVISORS LP
A - Grant
Prelude Non-Voting Common Stock
1.45M
$6.00
8.69M
2
$48.62M
2023-04-04
2023-04-06
HUANG JANE
President, CMO
M - Exercise
Restricted Stock Unit
-37,500
$0.00
1
$48.62M
2023-03-01
2023-03-02
LIM BRYANT DAVID
Chief Legal Officer, Corp Sec.
A - Grant
Employee Stock Option (Right to Buy)
250K
$0.00
1
$48.62M
2023-02-07
2023-02-09
COMBS ANDREW
EVP, Head of Chemistry
A - Grant
Employee Stock Option (right to buy)
135K
$0.00
1
$48.62M
2023-02-07
2023-02-09
CHARDONNET LAURENT
Chief Financial Officer
A - Grant
Employee Stock Option (right to buy)
135K
$0.00
1
$48.62M
2023-02-07
2023-02-09
HUANG JANE
President, CMO
A - Grant
Employee Stock Option (right to buy)
150K
$0.00
1
$48.62M
2023-02-07
2023-02-09
SCHERLE PEGGY
Chief Scientific Officer
A - Grant
Employee Stock Option (right to buy)
135K
$0.00
1
$48.62M
2023-02-07
2023-02-09
VADDI KRISHNA
CEO
A - Grant
Employee Stock Option (right to buy)
330K
$0.00
1
$48.62M
2022-12-21
2022-12-22
CHARDONNET LAURENT
Chief Financial Officer
A - Grant
Employee Stock Option (right to buy)
75,000
$0.00
1
$48.62M
2022-12-08
2022-12-12
CHARDONNET LAURENT
Chief Financial Officer
P - Purchase
Common Stock
10,000
$5.00
50,000
1
$48.62M
2022-06-17
2022-06-22
BABLER MARTIN
A - Grant
Director Stock Option (Right to Buy)
31,293
$0.00
1
$48.62M
2022-06-17
2022-06-22
BAKER BROS. ADVISORS LP
A - Grant
Non-Qualified Stock Options (right to buy)
34,300
$0.00
1
$48.62M
2022-06-17
2022-06-22
BONITA DAVID
A - Grant
Director Stock Option (Right to Buy)
34,300
$0.00
1
$48.62M
2022-06-17
2022-06-22
FRIEDMAN PAUL
A - Grant
Director Stock Option (Right to Buy)
34,300
$0.00
1
$48.62M
2022-06-17
2022-06-22
SANDOR VICTOR
A - Grant
Director Stock Option (Right to Buy)
34,300
$0.00
1
$48.62M
2022-06-01
2022-06-01
CHARDONNET LAURENT
Chief Financial Officer
P - Purchase
Common Stock
10,000
$4.00
40,000
1
$48.62M
2022-05-02
2022-05-04
HUANG JANE
President, CMO
A - Grant
Employee Stock Option (Right to Buy)
460K
$0.00
1
$48.62M
2022-04-01
2022-04-04
COMBS ANDREW
EVP, Head of Chemistry
M - Exercise
Employee Stock Option (right to buy)
-36,062
$0.00
1
$48.62M
2022-03-31
2022-04-04
COMBS ANDREW
EVP, Head of Chemistry
M - Exercise
Common Stock
36,062
$2.00
72,124
1
$48.62M
2022-03-21
2022-03-22
CHARDONNET LAURENT
Chief Financial Officer
A - Grant
Common Stock
6,500
$8.00
52,000
1
$48.62M
2022-02-15
2022-02-17
MOROSINI DEBORAH
EVP, Chief of Clinical Affairs
A - Grant
Employee Stock Option (right to buy)
90,000
$0.00
1
$48.62M
2022-02-15
2022-02-17
VADDI KRISHNA
CEO
A - Grant
Employee Stock Option (right to buy)
328K
$0.00
1
$48.62M
2022-02-15
2022-02-17
SCHERLE PEGGY
Chief Scientific Officer
A - Grant
Employee Stock Option (right to buy)
100K
$0.00
1
$48.62M
2022-02-15
2022-02-17
CHARDONNET LAURENT
Chief Financial Officer
A - Grant
Employee Stock Option (right to buy)
90,000
$0.00
1
$48.62M
2022-02-15
2022-02-17
COMBS ANDREW
EVP, Head of Chemistry
A - Grant
Employee Stock Option (right to buy)
100K
$0.00
1
$48.62M
2022-01-03
2022-01-05
SANDOR VICTOR
A - Grant
Director Stock Option (Right to Buy)
11,206
$0.00
1
$48.62M
2021-12-15
2021-12-17
MOROSINI DEBORAH
EVP, Chief of Clinical Affairs
M - Exercise
Employee Stock Option (right to buy)
-28,751
$0.00
3
$48.62M
2021-12-15
2021-12-17
MOROSINI DEBORAH
EVP, Chief of Clinical Affairs
M - Exercise
Common Stock
28,751
$12.00
345K
2
$48.62M
2021-12-15
2021-12-17
MOROSINI DEBORAH
EVP, Chief of Clinical Affairs
S - Sale
Common Stock
-28,751
$13.00
-374K
1
$48.62M
2021-12-14
2021-12-15
COMBS ANDREW
EVP, Head of Chemistry
P - Purchase
Common Stock
4,000
$12.00
48,000
1
$48.62M
2021-12-13
2021-12-15
COMBS ANDREW
EVP, Head of Chemistry
P - Purchase
Common Stock
4,000
$12.00
48,000
1
$48.62M
2021-12-13
2021-12-14
CHARDONNET LAURENT
Chief Financial Officer
A - Grant
Common Stock
5,000
$12.00
60,000
1
$48.62M
2021-11-29
2021-12-01
CHARDONNET LAURENT
Chief Financial Officer
A - Grant
Employee Stock Option (Right to Buy)
180K
$0.00
1
$48.62M
2021-11-16
2021-11-18
MOROSINI DEBORAH
EVP, Chief of Clinical Affairs
S - Sale
Common Stock
-28,751
$16.00
-460K
2
$48.62M
2021-11-16
2021-11-18
MOROSINI DEBORAH
EVP, Chief of Clinical Affairs
M - Exercise
Employee Stock Option (right to buy)
-28,751
$0.00
1
$48.62M
2021-11-16
2021-11-18
MOROSINI DEBORAH
EVP, Chief of Clinical Affairs
M - Exercise
Common Stock
28,751
$13.00
374K
1
$48.62M
2021-10-13
2021-10-14
SANDOR VICTOR
A - Grant
Director Stock Option (Right to Buy)
8,022
$0.00
1
$48.62M
2021-10-05
2021-10-06
MAURO DAVID
Chief Medical Officer
M - Exercise
Employee Stock Option (Right to Buy)
-15,000
$0.00
1
$48.62M
2021-10-05
2021-10-06
MAURO DAVID
Chief Medical Officer
M - Exercise
Common Stock
15,000
$2.00
30,000
1
$48.62M
2021-10-05
2021-10-06
MAURO DAVID
Chief Medical Officer
S - Sale
Common Stock
-15,000
$31.00
-465K
3
$48.62M
2021-09-07
2021-09-09
MAURO DAVID
Chief Medical Officer
S - Sale
Common Stock
-15,000
$37.00
-555K
3
$48.62M
2021-09-07
2021-09-09
MAURO DAVID
Chief Medical Officer
M - Exercise
Employee Stock Option (Right to Buy)
-15,000
$0.00
1
$48.62M
2021-09-07
2021-09-09
MAURO DAVID
Chief Medical Officer
M - Exercise
Common Stock
15,000
$2.00
30,000
1
$48.62M
2021-09-02
2021-09-07
PIERCE CHRISTOPHER
EVP and Chief of Business Oper
M - Exercise
Employee Stock Option (right to buy)
-17,000
$0.00
1
$48.62M
2021-09-02
2021-09-07
PIERCE CHRISTOPHER
EVP and Chief of Business Oper
S - Sale
Common Stock
-17,000
$42.00
-714K
3
$48.62M
2021-09-02
2021-09-07
PIERCE CHRISTOPHER
EVP and Chief of Business Oper
M - Exercise
Common Stock
17,000
$13.00
221K
1
$48.62M
2021-08-27
2021-08-30
SCHERLE PEGGY
Chief Scientific Officer
M - Exercise
Employee Stock Option (Right to Buy)
-6,014
$0.00
1
$48.62M
2021-08-27
2021-08-30
SCHERLE PEGGY
Chief Scientific Officer
M - Exercise
Common Stock
6,014
$1.00
6,014
1
$48.62M
2021-08-27
2021-08-30
SCHERLE PEGGY
Chief Scientific Officer
S - Sale
Common Stock
-6,014
$36.00
-217K
3
$48.62M
2021-08-26
2021-08-30
SCHERLE PEGGY
Chief Scientific Officer
M - Exercise
Common Stock
1,700
$1.00
1,700
1
$48.62M
2021-08-26
2021-08-30
SCHERLE PEGGY
Chief Scientific Officer
S - Sale
Common Stock
-1,700
$35.00
-59,500
1
$48.62M
2021-08-26
2021-08-30
SCHERLE PEGGY
Chief Scientific Officer
M - Exercise
Employee Stock Option (Right to Buy)
-1,700
$0.00
1
$48.62M
2021-08-25
2021-08-27
PIPER BRIAN
Chief Financial Officer
M - Exercise
Employee Stock Option (Right to Buy)
-8,333
$0.00
1
$48.62M
2021-08-25
2021-08-27
PIPER BRIAN
Chief Financial Officer
M - Exercise
Common Stock
8,333
$2.00
16,666
1
$48.62M
2021-08-25
2021-08-27
PIPER BRIAN
Chief Financial Officer
S - Sale
Common Stock
-8,333
$33.00
-275K
3
$48.62M
2021-08-13
2021-08-17
SCHERLE PEGGY
Chief Scientific Officer
S - Sale
Common Stock
-2,286
$35.00
-80,010
1
$48.62M
2021-08-13
2021-08-17
SCHERLE PEGGY
Chief Scientific Officer
M - Exercise
Employee Stock Option (Right to Buy)
-2,286
$0.00
2
$48.62M
2021-08-13
2021-08-17
SCHERLE PEGGY
Chief Scientific Officer
M - Exercise
Common Stock
2,286
$2.00
4,572
2
$48.62M
2021-08-05
2021-08-09
MAURO DAVID
Chief Medical Officer
M - Exercise
Common Stock
15,000
$2.00
30,000
1
$48.62M
2021-08-05
2021-08-09
MAURO DAVID
Chief Medical Officer
S - Sale
Common Stock
-15,000
$31.00
-465K
4
$48.62M
2021-08-05
2021-08-09
MAURO DAVID
Chief Medical Officer
M - Exercise
Employee Stock Option (Right to Buy)
-15,000
$0.00
1
$48.62M
2021-07-27
2021-07-29
SCHERLE PEGGY
Chief Scientific Officer
M - Exercise
Employee Stock Option (Right to Buy)
-20,000
$0.00
1
$48.62M
2021-07-27
2021-07-29
SCHERLE PEGGY
Chief Scientific Officer
M - Exercise
Common Stock
20,000
$1.00
20,000
1
$48.62M
2021-07-27
2021-07-29
SCHERLE PEGGY
Chief Scientific Officer
S - Sale
Common Stock
-20,000
$35.00
-700K
2
$48.62M
2021-07-20
2021-07-22
COMBS ANDREW
EVP, Head of Chemistry
A - Grant
Employee Stock Option (Right to Buy)
95,000
$0.00
1
$48.62M
2021-07-20
2021-07-22
MAURO DAVID
Chief Medical Officer
A - Grant
Employee Stock Option (Right to Buy)
95,000
$0.00
1
$48.62M
2021-07-20
2021-07-22
MOROSINI DEBORAH
EVP, Chief of Clinical Affairs
A - Grant
Employee Stock Option (Right to Buy)
85,000
$0.00
1
$48.62M
2021-07-20
2021-07-22
PIERCE CHRISTOPHER
EVP and Chief of Business Oper
A - Grant
Employee Stock Option (Right to Buy)
85,000
$0.00
1
$48.62M
2021-07-20
2021-07-22
PIPER BRIAN
Chief Financial Officer
A - Grant
Employee Stock Option (Right to Buy)
116K
$0.00
1
$48.62M
2021-07-20
2021-07-22
SCHERLE PEGGY
Chief Scientific Officer
A - Grant
Employee Stock Option (Right to Buy)
95,000
$0.00
1
$48.62M
2021-07-20
2021-07-22
VADDI KRISHNA
President, CEO
A - Grant
Employee Stock Option (Right to Buy)
286K
$0.00
1
$48.62M
2021-07-19
2021-07-20
BABLER MARTIN
A - Grant
Employee Stock Option (Right to Buy)
36,400
$0.00
1
$48.62M
2021-07-06
2021-07-08
MAURO DAVID
Chief Medical Officer
S - Sale
Common Stock
-15,000
$27.00
-405K
3
$48.62M
2021-07-06
2021-07-08
MAURO DAVID
Chief Medical Officer
M - Exercise
Employee Stock Option (Right to Buy)
-15,000
$0.00
1
$48.62M
2021-07-06
2021-07-08
MAURO DAVID
Chief Medical Officer
M - Exercise
Common Stock
15,000
$2.00
30,000
1
$48.62M
2021-06-18
2021-06-22
BONITA DAVID
A - Grant
Director Stock Option (Right to Buy)
23,344
$0.00
1
$48.62M
2021-06-18
2021-06-22
FRIEDMAN PAUL
A - Grant
Director Stock Option (Right to Buy)
23,344
$0.00
1
$48.62M
2021-06-18
2021-06-22
SANDOR VICTOR
A - Grant
Director Stock Option (Right to Buy)
23,344
$0.00
1
$48.62M
2021-06-18
2021-06-22
BAKER BROS. ADVISORS LP
A - Grant
Non-Qualified Stock Options (right to buy)
23,344
$0.00
1
$48.62M
2021-06-07
2021-06-09
MAURO DAVID
Chief Medical Officer
M - Exercise
Common Stock
-15,000
$0.00
1
$48.62M
2021-06-07
2021-06-09
MAURO DAVID
Chief Medical Officer
S - Sale
Common Stock
-15,000
$32.00
-480K
3
$48.62M
2021-06-07
2021-06-09
MAURO DAVID
Chief Medical Officer
M - Exercise
Common Stock
15,000
$2.00
30,000
1
$48.62M
2021-05-25
2021-05-27
PIPER BRIAN
Chief Financial Officer
M - Exercise
Employee Stock Option (Right to Buy)
-8,333
$0.00
1
$48.62M
2021-05-25
2021-05-27
PIPER BRIAN
Chief Financial Officer
M - Exercise
Common Stock
8,333
$2.00
16,666
1
$48.62M
2021-05-25
2021-05-27
PIPER BRIAN
Chief Financial Officer
S - Sale
Common Stock
-8,333
$34.00
-283K
4
$48.62M
2021-05-07
2021-05-11
SCHERLE PEGGY
Chief Scientific Officer
S - Sale
Common Stock
-10,000
$41.00
-410K
3
$48.62M
2021-05-07
2021-05-11
SCHERLE PEGGY
Chief Scientific Officer
M - Exercise
Employee Stock Option (right to buy)
-10,000
$0.00
1
$48.62M
2021-05-07
2021-05-11
SCHERLE PEGGY
Chief Scientific Officer
M - Exercise
Common Stock
10,000
$1.00
10,000
1
$48.62M
2021-05-05
2021-05-10
MAURO DAVID
Chief Medical Officer
S - Sale
Common Stock
-15,000
$40.00
-600K
3
$48.62M
2021-05-05
2021-05-10
MAURO DAVID
Chief Medical Officer
M - Exercise
Common Stock
-15,000
$0.00
1
$48.62M
2021-05-05
2021-05-10
MAURO DAVID
Chief Medical Officer
M - Exercise
Common Stock
15,000
$2.00
30,000
1
$48.62M
2021-04-29
2021-04-30
MOROSINI DEBORAH
EVP, Chief of Clinical Affairs
S - Sale
Common Stock
-3,223
$40.00
-129K
1
$48.62M
2021-04-29
2021-04-30
PIERCE CHRISTOPHER
EVP and Chief of Business Oper
S - Sale
Common Stock
-3,295
$40.00
-132K
1
$48.62M
2021-04-29
2021-04-30
MOROSINI DEBORAH
EVP, Chief of Clinical Affairs
M - Exercise
Employee Stock Option (right to buy)
-3,223
$0.00
1
$48.62M
2021-04-29
2021-04-30
MOROSINI DEBORAH
EVP, Chief of Clinical Affairs
M - Exercise
Common Stock
3,223
$2.00
6,446
1
$48.62M
2021-04-29
2021-04-30
PIERCE CHRISTOPHER
EVP and Chief of Business Oper
M - Exercise
Employee Stock Option (right to buy)
-3,295
$0.00
1
$48.62M
2021-04-29
2021-04-30
PIERCE CHRISTOPHER
EVP and Chief of Business Oper
M - Exercise
Common Stock
3,295
$2.00
6,590
1
$48.62M
2021-04-27
2021-04-29
MAURO DAVID
Chief Medical Officer
M - Exercise
Employee Stock Option (right to buy)
-25,000
$0.00
1
$48.62M
2021-04-27
2021-04-29
MAURO DAVID
Chief Medical Officer
M - Exercise
Common Stock
25,000
$2.00
50,000
1
$48.62M
2021-04-27
2021-04-29
MAURO DAVID
Chief Medical Officer
S - Sale
Common Stock
-25,000
$35.00
-875K
3
$48.62M
2021-04-19
2021-04-21
MAURO DAVID
Chief Medical Officer
S - Sale
Common Stock
-25,000
$31.00
-775K
2
$48.62M
2021-04-19
2021-04-21
MAURO DAVID
Chief Medical Officer
M - Exercise
Employee Stock Option (right to buy)
-25,000
$0.00
1
$48.62M
2021-04-19
2021-04-21
MAURO DAVID
Chief Medical Officer
M - Exercise
Common Stock
25,000
$2.00
50,000
1
$48.62M
2021-04-08
2021-04-15
SCHERLE PEGGY
Chief Scientific Officer
A - Grant
Common Stock
4,630
$1.00
4,630
1
$48.62M
2021-04-08
2021-04-15
MAURO DAVID
Chief Medical Officer
S - Sale
Common Stock
-9,617
$38.00
-365K
4
$48.62M
2021-04-08
2021-04-15
MOROSINI DEBORAH
EVP, Chief of Clinical Affairs
S - Sale
Common Stock
-100
$40.00
-4,000
1
$48.62M
2021-04-08
2021-04-15
PIERCE CHRISTOPHER
EVP and Chief of Business Oper
S - Sale
Common Stock
-200
$40.00
-8,000
1
$48.62M
2021-04-08
2021-04-15
SCHERLE PEGGY
Chief Scientific Officer
S - Sale
Common Stock
-4,630
$38.00
-176K
4
$48.62M
2021-04-08
2021-04-15
PIERCE CHRISTOPHER
EVP and Chief of Business Oper
A - Grant
Common Stock
200
$2.00
400
1
$48.62M
2021-04-08
2021-04-15
MAURO DAVID
Chief Medical Officer
M - Exercise
Employee Stock Option (right to buy)
-9,617
$0.00
1
$48.62M
2021-04-08
2021-04-15
MAURO DAVID
Chief Medical Officer
M - Exercise
Common Stock
9,617
$2.00
19,234
1
$48.62M
2021-04-08
2021-04-15
MOROSINI DEBORAH
EVP, Chief of Clinical Affairs
M - Exercise
Employee Stock Option (right to buy)
-100
$0.00
1
$48.62M
2021-04-08
2021-04-15
MOROSINI DEBORAH
EVP, Chief of Clinical Affairs
M - Exercise
Common Stock
100
$2.00
200
1
$48.62M
2021-04-08
2021-04-15
PIERCE CHRISTOPHER
EVP and Chief of Business Oper
M - Exercise
Employee Stock Option (right to buy)
-200
$0.00
1
$48.62M
2021-04-08
2021-04-15
SCHERLE PEGGY
Chief Scientific Officer
M - Exercise
Employee Stock Option (right to buy)
-4,630
$0.00
1
$48.62M
2021-04-07
2021-04-09
PIERCE CHRISTOPHER
EVP and Chief of Business Oper
S - Sale
Common Stock
-828
$40.00
-33,120
1
$48.62M
2021-04-07
2021-04-09
SCHERLE PEGGY
Chief Scientific Officer
S - Sale
Common Stock
-15,370
$39.00
-599K
3
$48.62M
2021-04-07
2021-04-09
PIERCE CHRISTOPHER
EVP and Chief of Business Oper
A - Grant
Common Stock
828
$2.00
1,656
1
$48.62M
2021-04-07
2021-04-09
SCHERLE PEGGY
Chief Scientific Officer
A - Grant
Common Stock
15,370
$1.00
15,370
1
$48.62M
2021-04-07
2021-04-09
MAURO DAVID
Chief Medical Officer
M - Exercise
Employee Stock Option (right to buy)
-15,383
$0.00
1
$48.62M
2021-04-07
2021-04-09
MAURO DAVID
Chief Medical Officer
M - Exercise
Common Stock
15,383
$2.00
30,766
1
$48.62M
2021-04-07
2021-04-09
MOROSINI DEBORAH
EVP, Chief of Clinical Affairs
M - Exercise
Employee Stock Option (right to buy)
-1,000
$0.00
1
$48.62M
2021-04-07
2021-04-09
MOROSINI DEBORAH
EVP, Chief of Clinical Affairs
M - Exercise
Common Stock
1,000
$2.00
2,000
1
$48.62M
2021-04-07
2021-04-09
PIERCE CHRISTOPHER
EVP and Chief of Business Oper
M - Exercise
Employee Stock Option (right to buy)
-828
$0.00
1
$48.62M
2021-04-07
2021-04-09
MAURO DAVID
Chief Medical Officer
S - Sale
Common Stock
-15,383
$39.00
-600K
2
$48.62M
2021-04-07
2021-04-09
MOROSINI DEBORAH
EVP, Chief of Clinical Affairs
S - Sale
Common Stock
-1,000
$40.00
-40,000
1
$48.62M
2021-04-07
2021-04-09
SCHERLE PEGGY
Chief Scientific Officer
M - Exercise
Employee Stock Option (right to buy)
-15,370
$0.00
1
$48.62M
2021-01-27
2021-01-29
BAKER BROS. ADVISORS LP
M - Exercise
Non-Qualified Stock Options (right to buy)
-10,376
2
$48.62M
2021-01-11
2021-01-13
BAKER BROS. ADVISORS LP
P - Purchase
Non-Voting Common Stock
167K
$60.00
10.00M
2
$48.62M
2021-01-11
2021-01-12
ORBIMED ADVISORS LLC
P - Purchase
Non-Voting Common Stock
41,700
$60.00
2.50M
1
$48.62M
2020-09-29
2020-09-30
BAKER BROS. ADVISORS LP
C - Conversion
Series B Convertible Preferred Stock
-7.36M
4
$48.62M
2020-09-29
2020-09-30
BAKER BROS. ADVISORS LP
C - Conversion
Series C Convertible Preferred Stock
-1.03M
4
$48.62M
2020-09-29
2020-09-30
BAKER BROS. ADVISORS LP
C - Conversion
Series A Convertible Preferred Stock
-5.49M
4
$48.62M
2020-09-24
2020-09-30
BONITA DAVID
A - Grant
Director Stock Option (right to buy)
46,688
$0.00
1
$48.62M
2020-09-24
2020-09-30
BAKER BROS. ADVISORS LP
A - Grant
Non-Qualified Stock Option (right to buy)
46,688
$0.00
1
$48.62M
2020-08-21
2020-09-30
BAKER BROS. ADVISORS LP
P - Purchase
Series C Preferred Stock
1.03M
$15.00
15M
2
$48.62M
2020-03-27
2020-09-30
BAKER BROS. ADVISORS LP
P - Purchase
Series B Preferred Stock
3.68M
$4.00
15M
2
$48.62M
2020-09-29
2020-09-29
MOROSINI DEBORAH
EVP, Chief of Clinical Affairs
P - Purchase
Common Stock
444
$19.00
8,436
1
$48.62M
2020-09-29
2020-09-29
COMBS ANDREW
EVP, Head of Chemistry
P - Purchase
Common Stock
1,000
$19.00
19,000
1
$48.62M
2020-09-29
2020-09-29
VADDI KRISHNA
President, CEO
C - Conversion
Series A Preferred Stock
-167K
$0.00
3
$48.62M
2020-09-29
2020-09-29
PIERCE CHRISTOPHER
EVP and Chief of Business Oper
P - Purchase
Common Stock
3,750
$19.00
71,250
1
$48.62M
2020-09-24
2020-09-28
SANDOR VICTOR
A - Grant
Director Stock Option (right to buy)
3,458
$0.00
1
$48.62M